脳深部刺激装置(DBS):医療機器パイプライン分析

◆英語タイトル:Deep Brain Stimulators (DBS) - Medical Devices Pipeline Assessment, 2019
◆商品コード:GDT20FB0152
◆発行会社(リサーチ会社):GlobalData
◆発行日:2019年12月
◆ページ数:164
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥420,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD8,000 ⇒換算¥840,000見積依頼/購入/質問フォーム
Enterprisewide Price(複数事業所内共有可)USD12,000 ⇒換算¥1,260,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

Deep Brain Stimulators (DBS) – Medical Devices Pipeline Assessment, 2019
Summary

GlobalData’s Medical Devices sector report, “Deep Brain Stimulators (DBS) – Medical Devices Pipeline Assessment, 2019″ provides an overview of Deep Brain Stimulators (DBS) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Deep Brain Stimulators (DBS) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Deep Brain Stimulators (DBS) under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Deep Brain Stimulators (DBS) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Deep Brain Stimulators (DBS) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

Table of Contents
1.1 List of Tables 6
1.2 List of Figures 10
2 Introduction 11
2.1 Deep Brain Stimulators (DBS) Overview 11
3 Products under Development 12
3.1 Deep Brain Stimulators (DBS) – Pipeline Products by Stage of Development 12
3.2 Deep Brain Stimulators (DBS) – Pipeline Products by Territory 13
3.3 Deep Brain Stimulators (DBS) – Pipeline Products by Regulatory Path 14
3.4 Deep Brain Stimulators (DBS) – Pipeline Products by Estimated Approval Date 15
3.5 Deep Brain Stimulators (DBS) – Ongoing Clinical Trials 16
4 Deep Brain Stimulators (DBS) – Pipeline Products under Development by Companies 17
4.1 Deep Brain Stimulators (DBS) Companies – Pipeline Products by Stage of Development 17
4.2 Deep Brain Stimulators (DBS) – Pipeline Products by Stage of Development 19
5 Deep Brain Stimulators (DBS) Companies and Product Overview 21
5.1 Adaptive Neuromodulation GmbH Company Overview 21
5.1.1 Adaptive Neuromodulation GmbH Pipeline Products & Ongoing Clinical Trials Overview 21
5.2 Adept Neuro SA Company Overview 22
5.2.1 Adept Neuro SA Pipeline Products & Ongoing Clinical Trials Overview 22
5.3 Aleva Neurotherapeutics SA Company Overview 23
5.3.1 Aleva Neurotherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview 23
5.4 Baylor College of Medicine Company Overview 24
5.4.1 Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 24
5.5 Bioinduction Limited Company Overview 25
5.5.1 Bioinduction Limited Pipeline Products & Ongoing Clinical Trials Overview 25
5.6 Boston Scientific Corp Company Overview 28
5.6.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 28
5.7 Brainsway Ltd Company Overview 34
5.7.1 Brainsway Ltd Pipeline Products & Ongoing Clinical Trials Overview 34
5.8 Cleveland Medical Devices Inc Company Overview 41
5.8.1 Cleveland Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 41
5.9 Clinatec Company Overview 42
5.9.1 Clinatec Pipeline Products & Ongoing Clinical Trials Overview 42
5.10 Cortera Neurotechnologies Inc Company Overview 43
5.10.1 Cortera Neurotechnologies Inc Pipeline Products & Ongoing Clinical Trials Overview 43
5.11 Deep Brain Innovations, LLC Company Overview 44
5.11.1 Deep Brain Innovations, LLC Pipeline Products & Ongoing Clinical Trials Overview 44
5.12 Enspire DBS Therapy Inc Company Overview 49
5.12.1 Enspire DBS Therapy Inc Pipeline Products & Ongoing Clinical Trials Overview 49
5.13 Functional Neuromodulation Inc. Company Overview 52
5.13.1 Functional Neuromodulation Inc. Pipeline Products & Ongoing Clinical Trials Overview 52
5.14 Louisiana State University Company Overview 57
5.14.1 Louisiana State University Pipeline Products & Ongoing Clinical Trials Overview 57
5.15 Massachusetts General Hospital Company Overview 58
5.15.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview 58
5.16 Massachusetts Institute of Technology Company Overview 60
5.16.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 60
5.17 Medtronic plc Company Overview 61
5.17.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 61
5.18 National Cheng-Kung University Hospital Company Overview 65
5.18.1 National Cheng-Kung University Hospital Pipeline Products & Ongoing Clinical Trials Overview 65
5.19 NeuroOne Inc Company Overview 66
5.19.1 NeuroOne Inc Pipeline Products & Ongoing Clinical Trials Overview 66
5.20 Neuroparticle Corp Company Overview 67
5.20.1 Neuroparticle Corp Pipeline Products & Ongoing Clinical Trials Overview 67
5.21 NeuroPro Technologies Inc Company Overview 68
5.21.1 NeuroPro Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 68
5.22 Neurosigma Inc Company Overview 69
5.22.1 Neurosigma Inc Pipeline Products & Ongoing Clinical Trials Overview 69
5.23 Newronika s.r.l. Company Overview 71
5.23.1 Newronika s.r.l. Pipeline Products & Ongoing Clinical Trials Overview 71
5.24 Nexeon MedSystems Inc Company Overview 74
5.24.1 Nexeon MedSystems Inc Pipeline Products & Ongoing Clinical Trials Overview 74
5.25 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 76
5.25.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 76
5.26 St. Jude Medical LLC Company Overview 77
5.26.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 77
5.27 Sunnybrook Health Sciences Centre Company Overview 82
5.27.1 Sunnybrook Health Sciences Centre Pipeline Products & Ongoing Clinical Trials Overview 82
5.28 SUNY Downstate Medical Center Company Overview 85
5.28.1 SUNY Downstate Medical Center Pipeline Products & Ongoing Clinical Trials Overview 85
5.29 University of California Los Angeles Company Overview 86
5.29.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 86
5.30 University of Central Florida Company Overview 88
5.30.1 University of Central Florida Pipeline Products & Ongoing Clinical Trials Overview 88
5.31 University of Florida Company Overview 89
5.31.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 89
5.32 University of Houston Company Overview 91
5.32.1 University of Houston Pipeline Products & Ongoing Clinical Trials Overview 91
5.33 University of Illinois Company Overview 92
5.33.1 University of Illinois Pipeline Products & Ongoing Clinical Trials Overview 92
5.34 University of Milan Company Overview 93
5.34.1 University of Milan Pipeline Products & Ongoing Clinical Trials Overview 93
5.35 University of Minnesota Company Overview 94
5.35.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 94
5.36 University of Oxford Company Overview 95
5.36.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 95
5.37 University of Rochester Company Overview 96
5.37.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 96
5.38 University of South Florida Company Overview 97
5.38.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 97
5.39 Wedge Therapeutics Company Overview 98
5.39.1 Wedge Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 98
6 Deep Brain Stimulators (DBS)- Recent Developments 99
6.1 Nov 25, 2019: BrainsWay reports third quarter 2019 financial results and operational highlights 99
6.2 Nov 25, 2019: BrainsWay appoints Medical Technology Industry Leader Christopher R. von Jako, Ph.D., as President and Chief Executive Officer 100
6.3 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 101
6.4 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 103
6.5 Nov 12, 2019: TMS program hosts open house to introduce Deep Transcranial Magnetic Stimulation (Deep TMS) Helmet to treat major depressive disorder (MDD) and Obsessive-Compulsive Disorder (OCD) 104
7 Appendix 161
7.1 Methodology 161
7.2 About GlobalData 164
7.3 Contact Us 164
7.4 Disclaimer 164

List of Tables
Table 1: Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development
Table 2: Deep Brain Stimulators (DBS) - Pipeline Products by Territory
Table 3: Deep Brain Stimulators (DBS) - Pipeline Products by Regulatory Path
Table 4: Deep Brain Stimulators (DBS) - Pipeline Products by Estimated Approval Date
Table 5: Deep Brain Stimulators (DBS) - Ongoing Clinical Trials
Table 6: Deep Brain Stimulators (DBS) Companies - Pipeline Products by Stage of Development
Table 7: Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development
Table 8: Adaptive Neuromodulation GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 9: CR-Capable Implant - Product Status
Table 10: CR-Capable Implant - Product Description
Table 11: Adept Neuro SA Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Stereo-Electro-Encephalo-Graphie Electrode - Product Status
Table 13: Stereo-Electro-Encephalo-Graphie Electrode - Product Description
Table 14: Aleva Neurotherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview
Table 15: directSTIM - Product Status
Table 16: directSTIM - Product Description
Table 17: Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Adaptive Deep Brain Stimulation (aDBS) Device - Product Status
Table 19: Adaptive Deep Brain Stimulation (aDBS) Device - Product Description
Table 20: Bioinduction Limited Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Picostim - Product Status
Table 22: Picostim - Product Description
Table 23: Bioinduction Limited - Ongoing Clinical Trials Overview
Table 24: Picostim - Simpler and Safer Deep Brain Stimulation for Parkinson's Disease
Table 25: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 26: Enspire DBS Therapy System - Traumatic Brain Injury - Product Status
Table 27: Enspire DBS Therapy System - Traumatic Brain Injury - Product Description
Table 28: Next Generation DBS System - Product Status
Table 29: Next Generation DBS System - Product Description
Table 30: Vercise Deep Brain Stimulation System - Dystonia - Product Status
Table 31: Vercise Deep Brain Stimulation System - Dystonia - Product Description
Table 32: Vercise Deep Brain Stimulation System - Tremors - Product Status
Table 33: Vercise Deep Brain Stimulation System - Tremors - Product Description
Table 34: Boston Scientific Corp - Ongoing Clinical Trials Overview
Table 35: Vercise Deep Brain Stimulation System - Dystonia - Deep Brain Stimulation (DBS) Retrospective Outcomes Study
Table 36: Vercise Deep Brain Stimulation System - Dystonia - Registry of Deep Brain Stimulation with the Vercise System for Treatment of Dystonia: Vercise DBS Dystonia Registry
Table 37: Vercise Deep Brain Stimulation System - Dystonia - Unlocking Dystonia From Parkinson's Disease With Directional DBS Technology
Table 38: Vercise Deep Brain Stimulation System - Tremors - Boston Scientific Registry of Deep Brain Stimulations for Treatment of Essential Tremor (ET): ET Registry
Table 39: Vercise Deep Brain Stimulation System - Tremors - Deep Brain Stimulation (DBS) Retrospective Outcomes Study
Table 40: Brainsway Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 41: Deep TMS System - Alzheimer's Disease - Product Status
Table 42: Deep TMS System - Alzheimer's Disease - Product Description
Table 43: Deep TMS System - Bipolar Disorder - Product Status
Table 44: Deep TMS System - Bipolar Disorder - Product Description
Table 45: Deep TMS System - PTSD - Product Status
Table 46: Deep TMS System - PTSD - Product Description
Table 47: Deep TMS System - Smoking Cessation - Product Status
Table 48: Deep TMS System - Smoking Cessation - Product Description
Table 49: Deep Transcrainal Magnetic Stimulation Device - Opioid Use Disorder - Product Status
Table 50: Deep Transcrainal Magnetic Stimulation Device - Opioid Use Disorder - Product Description
Table 51: Brainsway Ltd - Ongoing Clinical Trials Overview
Table 52: Deep TMS System - Bipolar Disorder - A Prospective, Double Blind, Randomized, Controlled Trial to Evaluate the Safety and Efficacy of the H1-coil Deep Transcranial Magnetic Stimulation (TMS) in Conjunction with Mood Stabilizers in Subjects with Bipolar Depression
Table 53: Deep TMS System - PTSD - A Prospective, Double Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of the Brainsway (HAC-Coil) Deep Transcranial Magnetic Stimulation (DTMS) System for the Treatment of Post-traumatic Stress Disorder (PTSD)
Table 54: Cleveland Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 55: ParkinTune - Product Status
Table 56: ParkinTune - Product Description
Table 57: Clinatec Pipeline Products & Ongoing Clinical Trials Overview
Table 58: Intracranial Deep Brain Stimulation Device - Product Status
Table 59: Intracranial Deep Brain Stimulation Device - Product Description
Table 60: Cortera Neurotechnologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 61: WAND - Product Status
Table 62: WAND - Product Description
Table 63: Deep Brain Innovations, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 64: TOPS Device - Alzheimer's disease - Product Status
Table 65: TOPS Device - Alzheimer's disease - Product Description
Table 66: TOPS Device - Depression - Product Status
Table 67: TOPS Device - Depression - Product Description
Table 68: TOPS Device - Epilepsy - Product Status
Table 69: TOPS Device - Epilepsy - Product Description
Table 70: TOPS Device - Obesity - Product Status
Table 71: TOPS Device - Obesity - Product Description

List of Figures
Figure 1: Deep Brain Stimulators (DBS) - Pipeline Products by Stage of Development
Figure 2: Deep Brain Stimulators (DBS) - Pipeline Products by Territory
Figure 3: Deep Brain Stimulators (DBS) - Pipeline Products by Regulatory Path
Figure 4: Deep Brain Stimulators (DBS) - Pipeline Products by Estimated Approval Date
Figure 5: Deep Brain Stimulators (DBS) - Ongoing Clinical Trials

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[脳深部刺激装置(DBS):医療機器パイプライン分析]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆